is retatrutide safe for type 1 diabetes UK 2026: Phase 3 Results Retatrutide vs Tirzepatide (2026): Differences

Both options are designed to introduce tirzepatide's dual GIP and GLP-1 activity gradually, at doses well below standard therapeutic thresholds, so your body can adapt at its own pace

No Trulicity settlement program has been announced, and there is no established average payout at this stage, so any figures discussed publicly should be treated as projections, not guaranteed outcomes

Even though Novo launched popular obesity drug Wegovy and diabetes treatment drug Ozempic in India after Lilly launched its rival Mounjaro and Zepbound, it "converted a mistake into an opportunity," as it came in at a much lower price and is now launching second brands, Kallianpur said

Korean J Internal Med

They obviously want healthy, productive workers, but they also want to minimize healthcare spending costs

"GLP-1 agonists have a favorable safety profile, with most side effects being mild and temporary